Clinical Trial Update: Phase II Study Evaluating Efficacy, Safety and Pharmacokinetics of Pasireotide in Patients With Dumping Syndrome [Phase 2]

View source ↗

Summary

A Phase II clinical trial evaluating the efficacy, safety and pharmacokinetics of pasireotide in dumping syndrome has completed with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dumping Syndrome

Drugs mentioned

• Pasireotide (pasireotide)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Dumping Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2017-05-10